2025年全球粘膜給藥裝置市場報告

預計未來幾年經粘膜給藥裝置市場規模將強勁成長。到 2029 年，這一數字將成長至 782.1 億美元，年複合成長率（CAGR）為 9.2%。預測期內的成長可歸因於智慧藥物輸送系統的發展、慢性病的增加、對個人化醫療的日益關注、對藥物需求高的人口老化以及意識的不斷增強。預測期內的關鍵趨勢包括擴大治療應用、個人化醫療的藥物輸送裝置客製化、監管部門的核准和指南、新興市場、環保設備和創新配方。

預計未來幾年慢性病盛行率的上升將推動粘膜給藥裝置市場的成長。慢性病通常會逐漸發展並持續很長一段時間，通常需要持續的醫療管理來控制症狀和預防併發症。慢性病的增加歸因於生活方式的選擇、人口老化、環境影響、醫療保健系統內部的挑戰和都市化因素。粘膜給藥裝置用於慢性疾病的管理，透過提供可控且高效的藥物輸送，確保持續的治療水平來控制症狀並提高患者的依從性。例如，根據美國非營利組織白血病和淋巴瘤協會（LLS）2023年8月的報告，美國大約每三分鐘就有一人被診斷出患有白血病、淋巴瘤或骨髓瘤。預計2023年將診斷出184,720例癌症病例，佔當年1,958,310例新發癌症病例的9.4％。因此，慢性病盛行率的上升正在推動粘膜給藥裝置市場的成長。

粘膜給藥裝置領域的主要企業正在積極尋求創新解決方案，例如專有的經皮吸收貼片給藥平台，旨在改善藥物吸收、提高患者依從性並提供便利。這些平台利用各自公司的持有技術透過皮膚輸送藥物，控制釋放並最佳化治療效果。例如，2024 年 1 月，美國生物技術公司 Starton Therapeutics Inc. 推出了全新專有經皮吸收貼片傳輸平台 STARSILON。該平台專門用於長時間輸送難以配製的活性藥物成分（API），從而擴大經皮給藥選擇並透過緩釋機制增強治療效果。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球粘膜給藥裝置 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球粘膜給藥裝置市場：成長率分析
• 全球粘膜給藥裝置市場表現：規模與成長，2019-2024
• 全球粘膜給藥裝置市場預測：規模與成長，2024-2029 年，2034 年
• 粘膜的全球總目標市場（TAM）

第6章市場區隔

• 全球粘膜給藥裝置市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 被動經經皮給藥
• 主動經皮給藥
• 全球經粘膜給藥裝置市場（依藥物類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
• 頰片
• 口腔噴霧劑
• 舌下膜和舌下片
• 凝膠
• 藥用糖果零食
• 其他藥物類型
• 全球經粘膜給藥裝置市場（依適應症、表現及預測），2019-2024 年、2024-2029 年、2034 年
• 疼痛管理
• 成癮治療
• 荷爾蒙療法
• 其他適應症
• 全球粘膜給藥裝置市場（依最終使用者、績效及預測）：2019-2024 年、2024-2029 年、2034 年
• 學術研究所
• 製藥和生物技術公司
• 診斷實驗室
• 醫院
• 全球粘膜給藥設備市場被動經經皮給藥細分市場，依類型、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 水庫系統
• 矩陣系統
• 微針系統
• 壓敏膠黏劑系統
• 全球粘膜給藥設備市場，按類型、性能和預測對主動經皮給藥進行細分，2019-2024 年、2024-2029 年、2034 年
• 離子電滲
• 超音波導入
• 電穿孔
• 熱燒蝕
• 微孔化

第7章 區域和國家分析

• 全球粘膜給藥裝置市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球粘膜給藥裝置市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 粘膜給藥裝置市場：競爭格局
• 粘膜給藥裝置市場：公司簡介
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Novartis AG
• Becton Dickinson and Company
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Catalent Inc.
• AptarGroup
• Glenmark Pharmaceuticals Limited
• Stevanato Group SpA
• Lifevision Healthcare Private Limited
• Noven Pharmaceuticals
• SAVA Healthcare Limited
• Antares Pharma Inc.
• Kaizen Pharmaceuticals Pvt. Ltd.
• Lucky Pharma Pvt. Ltd.
• Maya Biotech Pvt. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年粘膜給藥裝置市場：提供新機會的國家
• 2029年粘膜給藥裝置市場：細分市場帶來新機會
• 2029年粘膜給藥裝置市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

Transmucosal drug delivery devices are medical instruments designed to administer drugs through mucous membranes, such as those found in the mouth, nose, or rectum, allowing for rapid absorption into the bloodstream. These devices are particularly useful for delivering medications that are poorly absorbed by the gastrointestinal tract or require swift onset of action, such as pain relief or hormone therapy. Their primary function is to circumvent the digestive system, offering a direct and efficient route for drug delivery.

The two main categories of transmucosal drug delivery devices are passive transmucosal drug delivery and active transmucosal drug delivery. Passive transmucosal drug delivery involves the absorption of drugs through mucous membranes without external energy or active transport mechanisms. Various types of products include buccal tablets, oral sprays, sublingual films, wafers, gels, medicated confectionery, among others, used for treating conditions such as pain management, addiction, and hormonal therapies. End users include academic and research institutions, pharmaceutical and biotechnology firms, diagnostic laboratories, and hospitals.

The transmucosal drug delivery devices research report is one of a series of new reports from The Business Research Company that provides transmucosal drug delivery devices market statistics, including the transmucosal drug delivery devices industry's global market size, regional shares, competitors with a transmucosal drug delivery devices market share, detailed transmucosal drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the transmucosal drug delivery devices industry. This transmucosal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transmucosal drug delivery devices market size has grown strongly in recent years. It will grow from $50.24 billion in 2024 to $55.04 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to the need for rapid relief from angina, the effectiveness of sublingual delivery for quick absorption into the bloodstream, desire to bypass gastrointestinal degradation, development of buccal tablets, the need for non-invasive delivery of peptides and proteins.

The transmucosal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $78.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to the development of smart drug delivery systems, increased prevalence of chronic diseases, growing focus on personalized medicine, aging population with higher medication needs, and increased awareness. Major trends in the forecast period include expansion in therapeutic applications, customizing drug delivery devices for personalized medicine, regulatory approvals and guidelines, emerging markets, eco-friendly devices, and innovative formulations.

The increasing prevalence of chronic diseases is expected to drive the growth of the transmucosal drug delivery devices market in the coming years. Chronic diseases are long-lasting conditions that typically develop gradually and persist over time, often requiring ongoing medical management to control symptoms and prevent complications. The rise in chronic diseases can be attributed to factors such as lifestyle choices, aging populations, environmental influences, challenges within healthcare systems, and urbanization. Transmucosal drug delivery devices are employed in managing chronic diseases by providing controlled and efficient medication delivery, ensuring sustained therapeutic levels to manage symptoms and enhance patient adherence. For example, in August 2023, a report from the Leukemia & Lymphoma Society (LLS), a US-based nonprofit organization, indicated that in the US, a person is diagnosed with leukemia, lymphoma, or myeloma approximately every three minutes. In 2023, an estimated 184,720 individuals were expected to be diagnosed, accounting for 9.4% of the projected 1,958,310 new cancer cases for the year. Therefore, the rising prevalence of chronic diseases is fueling the growth of the transmucosal drug delivery devices market.

Leading companies in the transmucosal drug delivery devices sector are actively pursuing innovative solutions such as proprietary transdermal patch delivery platforms, which are designed to improve drug absorption, enhance patient compliance, and offer convenience. These platforms utilize specialized technologies owned by companies to administer medications through the skin, ensuring controlled release and optimized therapeutic outcomes. For example, in January 2024, Starton Therapeutics Inc., a US-based biotechnology firm, introduced STARSILON, a novel proprietary transdermal patch delivery platform. This platform is specifically designed to deliver difficult-to-formulate active pharmaceutical ingredients (APIs) over an extended period, thereby expanding the options for transdermal drug delivery and enhancing therapeutic efficacy through sustained release mechanisms.

In April 2023, Difgen Pharmaceuticals, an India-based pharmaceutical company, acquired Aveva Drug Delivery Services for an undisclosed sum. This strategic acquisition is intended to bolster Difgen Pharmaceuticals' drug delivery capabilities and incorporate advanced technologies into its pharmaceutical product portfolio. Aveva Drug Delivery Services, based in the US, specializes in manufacturing transdermal delivery systems (TDS) and oral dissolvable films (ODF).

Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.

North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transmucosal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transmucosal drug delivery devices market consists of sales of sublingual sprays, nasal drops, rectal suppositories, and sublingual tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transmucosal Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transmucosal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transmucosal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transmucosal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Passive Transdermal Drug Delivery; Active Transdermal Drug Delivery
• 2) By Drug Type: Buccal Tablets; Oral Sprays; Sublingual Films And Wafers; Gels; Medicated Confectionery; Other Drug Types
• 3) By Indication: Pain Management; Addiction Treatment; Hormonal Therapies; Others Indications
• 4) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Hospitals
• Subsegments:
• 1) By Passive Transdermal Drug Delivery: Reservoir Systems; Matrix Systems; Micro-Needle Systems; Pressure-Sensitive Adhesive Systems
• 2) By Active Transdermal Drug Delivery: Iontophoresis; Sonophoresis; Electroporation; Thermal Ablation; Microporation
• Companies Mentioned: Johnson & Johnson; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transmucosal Drug Delivery Devices Market Characteristics

3. Transmucosal Drug Delivery Devices Market Trends And Strategies

4. Transmucosal Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Transmucosal Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Transmucosal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Transmucosal Drug Delivery Devices Market Growth Rate Analysis
• 5.4. Global Transmucosal Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Transmucosal Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Transmucosal Drug Delivery Devices Total Addressable Market (TAM)

6. Transmucosal Drug Delivery Devices Market Segmentation

• 6.1. Global Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Passive Transdermal Drug Delivery
• Active Transdermal Drug Delivery
• 6.2. Global Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buccal Tablets
• Oral Sprays
• Sublingual Films And Wafers
• Gels
• Medicated Confectionery
• Other Drug Types
• 6.3. Global Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Addiction Treatment
• Hormonal Therapies
• Other Indications
• 6.4. Global Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Diagnostic Laboratories
• Hospitals
• 6.5. Global Transmucosal Drug Delivery Devices Market, Sub-Segmentation Of Passive Transdermal Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reservoir Systems
• Matrix Systems
• Micro-Needle Systems
• Pressure-Sensitive Adhesive Systems
• 6.6. Global Transmucosal Drug Delivery Devices Market, Sub-Segmentation Of Active Transdermal Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iontophoresis
• Sonophoresis
• Electroporation
• Thermal Ablation
• Microporation

7. Transmucosal Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Transmucosal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Transmucosal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transmucosal Drug Delivery Devices Market

• 8.1. Asia-Pacific Transmucosal Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transmucosal Drug Delivery Devices Market

• 9.1. China Transmucosal Drug Delivery Devices Market Overview
• 9.2. China Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transmucosal Drug Delivery Devices Market

• 10.1. India Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transmucosal Drug Delivery Devices Market

• 11.1. Japan Transmucosal Drug Delivery Devices Market Overview
• 11.2. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transmucosal Drug Delivery Devices Market

• 12.1. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transmucosal Drug Delivery Devices Market

• 13.1. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transmucosal Drug Delivery Devices Market

• 14.1. South Korea Transmucosal Drug Delivery Devices Market Overview
• 14.2. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transmucosal Drug Delivery Devices Market

• 15.1. Western Europe Transmucosal Drug Delivery Devices Market Overview
• 15.2. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transmucosal Drug Delivery Devices Market

• 16.1. UK Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transmucosal Drug Delivery Devices Market

• 17.1. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transmucosal Drug Delivery Devices Market

• 18.1. France Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transmucosal Drug Delivery Devices Market

• 19.1. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transmucosal Drug Delivery Devices Market

• 20.1. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transmucosal Drug Delivery Devices Market

• 21.1. Eastern Europe Transmucosal Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transmucosal Drug Delivery Devices Market

• 22.1. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transmucosal Drug Delivery Devices Market

• 23.1. North America Transmucosal Drug Delivery Devices Market Overview
• 23.2. North America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transmucosal Drug Delivery Devices Market

• 24.1. USA Transmucosal Drug Delivery Devices Market Overview
• 24.2. USA Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transmucosal Drug Delivery Devices Market

• 25.1. Canada Transmucosal Drug Delivery Devices Market Overview
• 25.2. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transmucosal Drug Delivery Devices Market

• 26.1. South America Transmucosal Drug Delivery Devices Market Overview
• 26.2. South America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transmucosal Drug Delivery Devices Market

• 27.1. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transmucosal Drug Delivery Devices Market

• 28.1. Middle East Transmucosal Drug Delivery Devices Market Overview
• 28.2. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transmucosal Drug Delivery Devices Market

• 29.1. Africa Transmucosal Drug Delivery Devices Market Overview
• 29.2. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transmucosal Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Transmucosal Drug Delivery Devices Market Competitive Landscape
• 30.2. Transmucosal Drug Delivery Devices Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Transmucosal Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Becton Dickinson and Company
• 31.3. Viatris Inc.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Catalent Inc.
• 31.6. AptarGroup
• 31.7. Glenmark Pharmaceuticals Limited
• 31.8. Stevanato Group S.p.A
• 31.9. Lifevision Healthcare Private Limited
• 31.10. Noven Pharmaceuticals
• 31.11. SAVA Healthcare Limited
• 31.12. Antares Pharma Inc.
• 31.13. Kaizen Pharmaceuticals Pvt. Ltd.
• 31.14. Lucky Pharma Pvt. Ltd.
• 31.15. Maya Biotech Pvt. Ltd.

32. Global Transmucosal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transmucosal Drug Delivery Devices Market

34. Recent Developments In The Transmucosal Drug Delivery Devices Market

35. Transmucosal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

• 35.1 Transmucosal Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Transmucosal Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Transmucosal Drug Delivery Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer